Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Baton who wrote (32832)	1/19/2007 10:16:13 AM
From: micdundee2	Read Replies (3) \| Respond to of 48461

some yhoooligan claiming FDA approval ??? odd Ive got 1 active link to msg boards but when I open another I get the hosed 'unavailable' msg

To: Baton who wrote (32832)	1/19/2007 4:16:40 PM
From: Buddy Smellgood	Respond to of 48461

TheSUBWAY.com: Announces the following stocks to its Breaking News List: Renhuang Pharmaceuticals, Inc. (OTCBB: RHGP), SIGA Technologies Inc (NASDAQ: SIGA), EasyLink Services Corporation (NASDAQ: EASY), JDSU (NASDAQ: JDSU). Renhuang Pharmaceuticals, Inc. (OTCBB: RHGP), just announced a major RMB 19 million (US$ 2.4 million) order from Anhui Huayuan Pharmaceutical Co. Ltd, which is one of the oldest and best-known pharmaceutical companies in China Renhuang Pharmaceuticals received the RMB 19 million order at the medical products purchasing conference in Taihe Town, Fuyang City in the Anhui Province. The conference is ranked as one of the biggest in the industry in China. Renhuang Pharmaceuticals is a leading bio-pharmaceutical company located in Harbin in the Heilongjiang Province in Northeast China. It is estimated that 70% of China's natural supply of Siberian Ginseng is currently controlled by the Company. Over 2000 sales agents are employed in seventy sales centers across twenty-four districts and cover over 50% of the greater China area and 80% of its population, including the most populous and developed Eastern China. The company also anticipates approval within six to nine months by State Food and Drug Administration ("SFDA") for up to five of its new Monoclonal Antibody Reagent Box series products. Other stocks highlighted include SIGA Technologies Inc (NASDAQ: SIGA): Hot Stocks List, up 15% on 2 million shares, EasyLink Services Corporation (NASDAQ: EASY): Hot Stocks List, up 20% on 1 million shares, JDSU (NASDAQ: JDSU): Hot Stocks List, up 7% on 7 million shares. "After a strong showing of a 5.6 percent annual growth rate in the first quarter, the economy slowed to just a 2.9 percent pace in the second. Economists look for even slower growth over the second half of the year." More is available at: thesubway.com. TheSUBWAY.com's Daily Stock Updates: